drugset / Trial / NCT07061925
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter, Dose-finding, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of ALC-2203 in Patients with Acute Bronchitis
Timeline
- Start
- 2025-04-23
- Primary completion
- 2025-11-21
- Completion
- 2025-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALC-2203-1 | Unknown | — | — |
| Subject | ALC-2203-2 | Unknown | — | — |
| Comparator | ALC-2203-AC | Unknown | — | — |